{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/25/3317434/0/en/Plus-Therapeutics-Secures-National-Coverage-Agreement-with-Elevance-Health-for-CNSide-Cerebrospinal-Fluid-Assay-for-Metastatic-CNS-Cancer.html", "message": "News view counter 816245 successfully enlarged"}